Filing summary
Issuer and period: The supplied 10-Q is for Security Devices International, Inc. (SDI), a development-stage less-than-lethal defense technology company, for the quarter ended February 29, 2012. This does not match the request metadata naming Byrna Technologies Inc.; the filing does not establish a connection between them.
Financial performance and position
- Revenue: None since inception; the filing reports no revenue for the quarter. Gross margin is not applicable.
- Quarterly results: Net loss was $252,431, versus $329,377 in the three months ended February 28, 2011. Operating loss was $208,330 versus $329,377. The 2012 quarter included a $215,143 research and product development cost recovery related to an Elad Engineering payable settlement.
- Cash flow: Operating cash use was $377,496 and investing cash use was $5,079. Financing provided $825,000, resulting in a $442,425 increase in cash. Cash at quarter-end was $557,260.
- Liquidity and balance sheet: Current assets were $689,420 and current liabilities were $376,519, implying working capital of $312,901. Total assets were $710,629; total liabilities were $1,884,572; stockholders’ deficit was $1,173,943.
- Debt: Convertible debentures had a reported carrying value of $1,651,852, of which $143,799 was current. Terms include 8% or 10% interest, conversion rights and, for certain issues, down-round protections. The company issued $825,000 of debentures during the quarter and another $45,000 after quarter-end.
- Share count: 26,828,050 common shares were outstanding at February 29, 2012 and April 12, 2012. The company also granted 905,000 options and issued 800,000 warrants during the quarter.
Material changes and business developments
- Cash increased from $114,835 at November 30, 2011 to $557,260, primarily reflecting quarter financing.
- SDI continued development and testing of its BIP40 blunt-impact and WEP40 wireless-electric 40mm rounds. BIP40 production molds were approximately 85% complete at quarter-end.
- SDI signed a five-year, non-exclusive teaming and marketing agreement with Chemring Ordnance Inc. for global marketing and manufacturing support; products are to be branded under Chemring.
- On March 13, 2012, SDI agreed to settle a $315,143 payable to former contractor Elad Engineering for $100,000, paid March 20. The company recorded a $215,143 recovery in the quarter because the settlement was agreed in principle by February 29. Related patent applications were to be transferred to SDI’s U.S. patent counsel.
Outlook, risks and unusual items
- Management estimated capital needs for the 12 months ending February 28, 2013 at $545,000: $110,000 for development and production and $435,000 for general and administrative expenses.
- The filing states SDI had no committed arrangements for additional capital and would be unable to fund anticipated requirements without raising capital. Management disclosed substantial doubt about the company’s ability to continue as a going concern, citing no operating cash-flow source, accumulated losses of $17,528,639 and expected further development losses.
- The company remained pre-revenue and depended on successful product development, production, financing and market adoption. The quarter’s loss included substantial noncash stock-based compensation over the company’s development-stage history; cash-flow reconciliation identifies $213,440 of stock-based compensation for the quarter.
- Commitments included a $123,675 purchase order for BIP40 injection molds, with $87,146 advanced by quarter-end, and consulting and office lease obligations. The filing says results for the quarter are not necessarily indicative of full-year results.
- Disclosure controls were assessed as effective, with no material quarter changes to internal control over financial reporting reported.
Important facts for investors to verify
- Confirm the issuer identity: the filing is for Security Devices International, Inc., not Byrna Technologies Inc.
- Review the complete debt agreements, maturity dates, conversion terms, security/default provisions and subsequent financing activity.
- Assess cash runway against the stated $545,000 funding requirement and the company’s lack of committed additional capital.
- Verify the status, cost and completion of BIP40 molds, testing, product commercialization and the Chemring arrangement.
- Review the Elad settlement accounting and related transfer of patent applications and options into warrants.